II. Epidemiology
- HIV and Tobacco Abuse both play major roles in the increased risk of COPD and Lung Cancer in HIV patients
III. Pathophysiology
- Chronic immune activation and systemic inflammation causes increased Prevalence of lung disease in HIV
- Noninfectious Respiratory Conditions with higher Prevalence in HIV (despite Antiretroviral therapy)
- Obstructive Lung Disease (Asthma, COPD)
- Precaution: Protease Inhibitors have Drug Interactions with longterm Inhaled Corticosteroids
- Pulmonary Hypertension
- Interstitial Lung Disease
- Lung Cancer
- Recurrent respiratory infections
- Tobacco Abuse is more common in HIV patients
- Obstructive Lung Disease (Asthma, COPD)
IV. Causes: General lung findings in AIDS
- Typical Bacterial Pneumonias are the most common Bacterial Pneumonias seen in HIV and AIDS patients
-
Mycobacterium
-
Tuberculosis
- May occur at any CD4, but especially occurs in advanced HIV with CD4 < 500
- Suggestive findings include cavitary lesions, fever >7 days, weight loss
- More common with incarceration, Homelessness, congregate housing, travel to endemic regions
- Mycobacterium Avium Complex or MAC (AIDS)
-
Tuberculosis
- Parasitic
-
Viruses (CD4 <50)
- Cytomegalovirus (CMV)
- Herpes Simplex Virus (HSV)
- Fungal (advanced HIV and AIDS)
- CD4<200
- Pneumocystis jiroveci Pneumonia (PCP Pneumonia)
- Interstitial Infiltrates AND Thrush (Odds Ratio 11.8)
- Other predictive findings include exertional Dyspnea, inspiratory crackles, subacute disease course
- Pneumocystis jiroveci Pneumonia (PCP Pneumonia)
- CD4<50
- Other less common endemic fungi (consider in those living in or traveling to endemic regions)
- CD4<200
- Malignancy
V. Causes: Cavitary Lesions
- Tuberculosis
- Aspergillus
- Pneumocystis jiroveci Pneumonia (Pneumocystis carinii)
- Pneumococcus
- Cryptococcus neoformans
-
Rhodococcus equi
- Upper lobe lung cavitary lesions with air fluid levels (distinguishes from Tuberculosis)
- Nocardia
- Gram Negative Bacilli (especially Pseudomonas)
VI. Causes: Nodular lesions
VII. Causes: Hilar Adenopathy
VIII. Causes: Pleural Effusion
IX. Prevention
X. References
- Parker and Bond (2023) Crit Dec Emerg Med 37(10): 4-9
- Swadron (2019) Pulmonology 2, CCME Board Review, accessed 6/18/2019
- Chu (2017) Am Fam Physician 96(3): 161-9 [PubMed]
- Jaqua (2026) Am Fam Physician 113(1): 71-9 [PubMed]